상세정보
- |Home >
- 상세정보
부가기능
BRIEF COMMUNICATIONS - Anti-CD20 Chimeric Monoclonal Antibody Treatment of Refractory Immune-Mediated Thrombocytopenia in a Patient with Chronic Graft-versus-Host Disease - The efficacy of rituximab for immune-mediated thrombocytopenia in the patient described here suggests that this drug may have activity in other autoimmune diseases or chronic graft-versus-host disease/
기사 상세정보
소장정보
- 소장정보
| No. | 권호·제본정보 보기 | 소장처 | 소장사항 | 청구기호 | 구독 | 최근입수호 |
|---|---|---|---|---|---|---|
| 1 | 의학도서관/연속간행물/ | 616 A613 | 구독중단 | Vol.157 no.12 |
하단메뉴
